Exploring the ESKAPE maze: Pneumonias, resistance and therapeutic perspectives
References
- Santajit, Sirijan, and Nitaya Indrawattana. “Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.” BioMed research international vol. 2016 (2016): 2475067. doi:10.1155/2016/2475067
- Ablakimova, Nurgul, et al. “Microbial Landscape and Antibiotic-Susceptibility Profiles of Microorganisms in Patients with Bacterial Pneumonia: A Comparative Cross-Sectional Study of COVID-19 and Non-COVID-19 Cases in Aktobe, Kazakhstan.” Antibiotics (Basel, Switzerland) vol. 12,8 1297. 8 Aug. 2023, doi:10.3390/antibiotics12081297
- Choby, J E et al. “Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives.” Journal of Internal Medicine vol. 287,3 (2020): 283-300. doi:10.1111/joim.13007
- Martin, Rebekah M, and Michael A Bachman. “Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae.” Frontiers in cellular and infection microbiology vol. 8 4. 22 Jan. 2018, doi:10.3389/fcimb.2018.00004
- Dong, Ning, et al. “Klebsiella species: Taxonomy, hypervirulence, and multidrug resistance.” EBioMedicine vol. 79 (2022): 103998. doi:10.1016/j.ebiom.2022.103998
- Wang, Guoying et al. “The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae.” International journal of environmental research and public health vol. 17,17 6278. 28 Aug. 2020, doi:10.3390/ijerph17176278
- Ramirez, Maria Soledad et al. “Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace.” Biomolecules vol. 10,5 720. 6 May. 2020, doi:10.3390/biom10050720
- Ramirez, Maria Soledad et al. “Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace.” Biomolecules vol. 10,5 720. 6 May. 2020, doi:10.3390/biom10050720
- Tang, Jiaxin, et al. “The Protective Role of Interleukin 17A in Acinetobacter baumannii Pneumonia Is Associated with Candida albicans in the Airway.” Infection and immunity vol. 91,1 (2023): e0037822. doi:10.1128/iai.00378-22
- Liu, Ai-Ran, et al. “Role of immunodeficiency in Acinetobacter baumannii associated pneumonia in mice.” Chinese Medical Journal vol. 133,18 (2020): 2161-2169. doi:10.1097/CM9.0000000000001027
- Hernandez, Antonio, et al. “INTRAPULMONARY TREATMENT WITH A NOVEL TLR4 AGONIST CONFERS PROTECTION AGAINST KLEBSIELLA PNEUMONIA.” Shock (Augusta, Ga.) vol. 58,4 (2022): 295-303. doi:10.1097/SHK.0000000000001977
- Li, Yanping et al. “Klebsiella pneumonia and Its Antibiotic Resistance: A Bibliometric Analysis.” BioMed research international vol. 2022 1668789. 6 Jun. 2022, doi:10.1155/2022/1668789
- Chen, I-Ren, et al. “Clinical characteristics and outcomes of 56 patients with pneumonia caused by carbapenemresistant Klebsiella pneumonia.” Journal of Global Antimicrobial Resistance vol. 25 (2021): 326-330. doi:10.1016/j. jgar.2021.03.028
- De Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ. Antimicrobial Resistance in ESKAPE Pathogens. Clin Microbiol Rev. 2020 May 13;33(3):e00181-19. Doi: 10.1128/CMR.00181-19. PMID: 32404435; PMCID: PMC7227449.
- Chang, Ko-Yun, et al. “Clinical Features and Antimicrobial Susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii Complex Isolates in Intensive Care Patients with Chronic Obstructive Pulmonary Disease and Community-Acquired Pneumonia in Taiwan.” International journal of chronic obstructive pulmonary disease vol. 16 1801-1811. 17 Jun. 2021, doi:10.2147/COPD.S311714
- Liang, C-A et al. “Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenemresistant Acinetobacter baumannii.” Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases vol. 24,8 (2018): 908. e1-908.e7. doi:10.1016/j.cmi.2017.10.033
- Zhou, Yangang, et al. “Clinical experience with tigecycline in treating hospital-acquired pneumonia caused by multidrug- resistant Acinetobacter baumannii.” BMC pharmacology & toxicology vol. 20,1 19. 25 Apr. 2019, doi:10.1186/s40360-019-0300-3
- Pei, Yongjian, et al. “Nomogram for predicting 90-day mortality in patients with Acinetobacter baumannii-caused hospital-acquired and ventilator-associated pneumonia in the respiratory intensive care unit.” The Journal of International Medical Research vol. 51,3 (2023): 3000605231161481. doi:10.1177/03000605231161481
- Russo, Alessandro, et al. “Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug- Resistant Acinetobacter baumannii: A Prospective, Observational Study.” Infectious diseases and therapy vol. 10,1 (2021): 187-200. doi:10.1007/s40121-020-00357-8
- Jeong, Yun-Jeong, et al. “Prospective observational study of the impact of plasma colistin levels in patients with carbapenem-resistant Acinetobacter baumannii pneumonia.” Journal of Global Antimicrobial Resistance vol. 27 (2021): 315-323. doi:10.1016/j. jgar.2021.10.017
- Manfi Ahmed, S et al. “Immunological Evaluation of Individuals Infected with Acinetobacter baumannii.” Archives of Razi Institute vol. 77,5 1813-1819. 31 Oct. 2022, doi:10.22092/ARI.2022.357980.2126
- Komiya, Kosaku, et al. “Radiological patterns and prognosis in elderly patients with acute Klebsiella pneumoniae pneumonia: A retrospective study.” Medicine vol. 101,32 (2022): e29734. doi:10.1097/MD.0000000000029734
- Sreenath, K et al. “Coinfections with Other Respiratory Pathogens among Patients with COVID-19.” Microbiology spectrum vol. 9,1 (2021): e0016321. doi:10.1128/Spectrum.00163-21
- Zaidan, Noor et al. “Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination.” Antimicrobial agents and chemotherapy vol. 65,11 (2021): e0092421. doi:10.1128/AAC.00924-21
- Falcone, Marco, et al. “Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.” Antimicrobial agents and chemotherapy vol. 66,5 (2022): e0214221. doi:10.1128/aac.02142-21
- Karakonstantis, Stamatis, et al. “Treatment options for K. pneumoniae, P. aeruginosa, and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins, and tigecycline: an approach based on the mechanisms of resistance to carbapenems.” Infection vol. 48,6 (2020): 835-851. doi:10.1007/s15010-020-01520-6
- Bassetti, Matteo, et al. “New antibiotics for Gram-negative pneumonia.” European Respiratory Review: An Official Journal of the European Respiratory Society vol. 31,166 220119. 21 Dec. 2022, doi:10.1183/16000617.0119-2022
- Deng, Yanling, et al. “Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia.” BMC Infectious Diseases vol. 22,1 795. 21 Oct. 2022, doi:10.1186/s12879-022-07778-5
- Pulingam, Thiruchelvi, et al. “Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome.” European Journal of pharmaceutical sciences: official journal of the European Federation for Pharmaceutical Sciences vol. 170 (2022): 106103. doi:10.1016/j. ejps.2021.106103
- Piperaki ET, Tzouvelekis LS, Miriagou V, Daikos GL. Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment. Clin Microbiol Infect. 2019 Aug;25(8):951-957. doi: 10.1016/j.cmi.2019.03.014. Epub 2019 Mar 23. PMID: 30914347.)
- Sorieul, Charlotte, et al. “Glycoconjugate vaccines against antimicrobial-resistant pathogens.” Expert review of vaccines vol. 22,1 (2023): 1055-1078. doi:10.1080/14760584.20 23.2274955
- Semenec, Lucie et al. “Cross-protection and cross-feeding between Klebsiella pneumoniae and Acinetobacter baumannii promotes their co-existence.” Nature communications vol. 14,1 702. 9 Feb. 2023, doi:10.1038/s41467-023-36252-2
- Ahn, Danielle et al. “Acquired resistance to innate immune clearance promotes Klebsiella pneumoniae ST258 pulmonary infection.” JCI insight vol. 1,17 e89704. 20 Oct. 2016, doi:10.1172/jci. insight.89704
- Dumigan, Amy et al. “In vivo single-cell transcriptomics reveal Klebsiella pneumoniae skews lung macrophages to promote infection.” EMBO molecular medicine vol. 14,12 (2022): e16888. doi:10.15252/emmm.202216888
- Catalano, Alessia et al. “Antibiotic-Resistant ESKAPE Pathogens and COVID-19: The Pandemic beyond the Pandemic.” Viruses vol. 15,9 1843. 30 Aug. 2023, doi:10.3390/v15091843
Language: English
Page range: 140 - 147
Published on: Nov 7, 2024
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Related subjects:
© 2024 Ioana Adelina Stoian, Andreea Zabară Antal, Paula Vasilache Antohi, Victoria Țău, Adriana Loredana Pintilie, Antigona Carmen Trofor, Radu Adrian Crișan-Dabija, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.